logo
Five years after COVID-19 was declared a pandemic, scientists still have questions

Five years after COVID-19 was declared a pandemic, scientists still have questions

Yahoo11-03-2025

Tuesday marks the fifth anniversary of the World Health Organization declaring COVID-19 a pandemic: Since then, scientists have linked the disease to an estimated 20 million deaths worldwide and $16 trillion in costs.
The pandemic also spurred rapid, unprecedented scientific achievement: As one scientist said in December, 2020, 'in the last 11 months, probably 10 years' work has been done.'
Researchers developed and tested mRNA vaccines for the first time, ushering in the possibility of immunizations for conditions, from cancer to heart disease. The consensus understanding of our immune system evolved rapidly, while behavioral and mental health research also flourished.
Many unanswered questions remain: Public health experts expect that a future pandemic is not only possible but probable, and as the US — the world's largest national donor — pulls back much of its global health funding, scientists are increasingly worried that another outbreak would not see the same collective response.
COVID-19 spread globally at devastating speeds, matched 'only by the pace of scientific insights,' Nature wrote in 2020. Weeks after the first reports of the disease emerged from Wuhan, geneticists had mapped and published the virus' genome, enabling the first mass rollout of mRNA vaccines, which harnessed that genetic blueprint to prime the immune system to fight a disease. The urgency of the pandemic spurred an 'all hands on deck' approach, one scientist said at the time, with global collaboration and information sharing crucial to those early breakthroughs. However, as concern over COVID-19 has waned and geopolitical tensions between the US and China have risen, declining scientific collaboration between the two nations has led to concerns that future research breakthroughs could be held back.
The unique conditions of a pandemic offered diverse avenues for discovery, The New York Times wrote. The flu receded in the first years of the pandemic as the measures people took to avoid getting COVID-19 also protected them from other respiratory diseases. Researchers also found that, even if both a husband and wife are at home all day, women still do a larger share of the housework. In sports, behavioral scientists found that fans were crucial to the so-called 'home-field advantage,' whereby teams tend to win when they play at their own stadiums — without an audience, the advantage disappeared.
It became clear early in the pandemic that COVID-19 could, in some cases, cause long-lasting, adverse changes to a person's health and immune system function — a collection of symptoms that has since come to be known as 'Long Covid.' Some 3.6% of American adults are estimated to have Long Covid: Often left in a kind of 'medical limbo,' these individuals' long-term care costs and needs remain unclear, MSNBC noted. Ed Yong, who won a Pulitzer Prize for his pandemic reporting for The Atlantic, warned recently that the relative neglect of Long Covid leaves societies less prepared for future pandemics: 'Once the problem abates, so, too does everything else… and we lapse into the same level of unpreparedness that led to the panic.'

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

There's one vice RFK Jr. isn't talking about
There's one vice RFK Jr. isn't talking about

Politico

time2 hours ago

  • Politico

There's one vice RFK Jr. isn't talking about

Robert F. Kennedy Jr. has made it his mission to remind Americans that they need to get off the couch and lay off the junk food. But there's one vice he's not talking about: smoking. That's troubled anti-smoking activists, researchers who focus on the diseases tobacco causes and Democrats in Congress who point out that smoking, despite a marked decline in recent years, still leads to more preventable deaths than anything else. Even so, Kennedy didn't mention the health impacts of smoking once in last month's Make America Healthy Again report assessing the biggest threats to Americans' health. That marks a turning point from the priorities of public health officials going back decades, including the Biden administration's, which targeted smoking as part of a moonshot plan to halve cancer death rates. Anti-tobacco advocates fear deemphasizing the dangers of tobacco could slow or even halt progress in driving down smoking rates. 'Attempting to combat chronic disease without tobacco control is like attempting a triathlon without a bicycle,' said Brian King, whom Kennedy pushed out of his job as the Food and Drug Administration's top tobacco regulator in April. 'You're destined for failure before leaving the starting line.' Since President Donald Trump's inauguration, his health agencies appear to have shelved two moves King planned to combat smoking, banning the last remaining legal cigarette flavoring, menthol, and requiring companies to reduce the amount of nicotine in their products. Nicotine is what makes cigarettes addictive. But an HHS spokesperson said the department 'remains steadfast in its mission to protect and promote public health,' adding that the MAHA report is not an 'exhaustive inventory of every HHS program or public health challenge.' 'HHS agencies continue to carry out their responsibilities, including work on tobacco control, with the highest level of integrity and commitment to the American public,' the spokesperson said. A sustained public health campaign to educate Americans about smoking's risks over decades has driven a huge decrease in use. In the 1960s, more than 4 in 10 adults smoked cigarettes. Now it's fewer than 1 in 8. And the public health success among kids is even starker. Fewer than 1 in 26 now smoke cigarettes, according to an analysis of federal data. The negative health impacts of tobacco use are well-studied and vast. For years it has been the top preventable cause of death in the United States, contributing to cancer, heart disease and stroke. But when Sen. Dick Durbin (D-Ill.) quizzed Kennedy about that during a budget hearing last month, asking him to name the 'No. 1 cause of preventable death in America today,' Kennedy was stumped. 'I'm not sure what you're talking about,' he said. Kennedy's apparent lack of interest in combating smoking — the word 'tobacco' appears in the MAHA report only within the context of his concerns about food marketing while 'smoking' and 'cigarettes' are never mentioned — also suggests this Trump administration won't be like the first. Then, Trump's FDA commissioner, Scott Gottlieb, put the menthol ban and the limits on nicotine on the table, drawing applause from anti-smoking activists. Congress permitted the agency to make those moves in a 2009 law. That law banned flavorings except menthol — which is a cash cow for Marlboro cigarette maker Philip Morris, whose support helped get the law passed — but gave the FDA the power to decide whether to ban it. It also gave the agency the power to force cigarette companies to reduce nicotine levels. The Obama administration didn't do so. President Joe Biden proposed limiting nicotine levels after the 2024 election but never finalized the rule. A Biden plan to ban menthol cigarettes in 2022 was also not finalized. Menthol is popular among Black smokers and some Democrats feared a ban could alienate crucial voters in a presidential election year. Jerome Adams, who was surgeon general during the first Trump term, said he wants Kennedy to prioritize the tobacco regulations laid out in Gottlieb's tobacco regulation plan — an effort he said would benefit youth and marginalized communities that are disproportionately impacted by menthol cigarettes. 'These proposed regulations align with the MAHA movement's focus on preventing chronic diseases,' Adams said. The tobacco industry spent heavily on Trump's 2024 campaign — and already has a lot to show for it. Trump pledged to 'save' vaping on his social media site, Truth Social, in September after meeting with Vapor Technology Association Executive Director Tony Abboud. The Trump administration pushed King — whom the tobacco industry had criticized for years — out of his job leading the FDA's Center for Tobacco Products. Job dismissals led by Trump's Department of Government Efficiency also gutted the CDC Office on Smoking and Health, which oversees federal smoking cessation programs and studies. The Trump administration also slashed funds the National Institutes of Health disburses to research facilities, which scientists say could imperil tobacco smoking studies. Asked about the industry's contributions to the Trump campaign, White House spokesperson Kush Desai wrote in an email, 'the only special interest guiding the Administration's decision-making is the best interest of the American people.' Tobacco-control advocates say Trump's early moves could undermine the country's progress diminishing smoking and the diseases it causes. 'These levels are decreasing because we have made such a commitment over the past few decades to enact things to work to get these levels down,' said Catharine Young, a Biden administration official who worked on his cancer moonshot initiative. 'But if you stop that or if you don't increase that effort, they're not going to continue to go down. They're either going to flat line, or they're going to start rising again.' Both Democratic and Republican administrations have hesitated to use all the regulatory authorities the 2009 law granted them. After Gottlieb resigned in March 2019, the agency's efforts to advance his 2017 tobacco plan were snuffed out. 'With his resignation, we lost the champion for the 2017 plan, and some months after he resigned, I was literally ordered by political appointees at FDA to stop talking publicly about menthol and nicotine,' said Mitch Zeller, who led the FDA's Center for Tobacco Products before King. Ultimately, Zeller wasn't able to implement a menthol ban or nicotine limits during any of the three administrations he served. During Biden's administration, then-FDA Commissioner Robert Califf enlisted allies outside the government to lobby the White House after agency efforts to ban menthol cigarettes were held up at the Office of Management and Budget. But the final rule was not published before Biden left office. 'They caved to political pressure from cigarette companies,' Zeller said. The FDA estimated the plan to limit nicotine levels in cigarettes proposed during the Biden administration would avert 4.3 million deaths and prevent 48 million youth and young adults from starting habitual cigarette smoking by the end of the century if implemented. And banning menthol cigarettes in the U.S. would cut 324,000 to 654,000 smoking-attributable deaths by 2060, according to modeling studies cited in the 2022 proposal. Luis Pinto, a spokesperson for Reynolds American, the maker of Lucky Strike, Camel and Newport cigarettes, said the company has not yet met with Trump's FDA commissioner, Marty Makary. Pinto said the company is opposed to a menthol cigarette ban because it believes there are 'more effective and sustainable ways to help adult smokers transition away from combustible cigarettes.' 'Rather than setting a nicotine standard, the focus should be on expanding access to a diverse and innovative portfolio of potentially reduced-risk products,' Pinto said. 'Tobacco harm reduction, not prohibition, is the most effective path forward in reducing the health impacts of smoking.' On Capitol Hill, Kennedy has rarely discussed tobacco despite his focus on preventing chronic disease, disappointing lawmakers like Durbin, the second ranking Democrat in the Senate. In an interview with POLITICO, Durbin emphasized the tobacco industry is still a threat to public health, especially as it markets more novel forms of nicotine exposure like vaping, which has become popular among younger Americans. 'The tobacco companies have not given up. Their basic approach is to addict children to their product, and so now they're using vaping and [other] devices to get … high schoolers in America addicted to forms of nicotine,' Durbin said, referring to Gottlieb as a hero. 'I just don't think you can credibly say you're addressing public health in America and ignore tobacco and vaping.' King, who's now with the Campaign for Tobacco-Free Kids, an anti-smoking group, is still hoping to convince Trump officials that going after tobacco needs to be part of the MAHA agenda. And he says he sees hope in the FDA's crackdown on illegal e-cigarettes, which he interprets as a sign the government is looking to snuff out unapproved vaping products. 'We have seen the decimation of tobacco control infrastructure,' King said. 'It's important you have the resources and the people.'

Biden's COVID czar hammers RFK Jr. over vaccine panel overhaul
Biden's COVID czar hammers RFK Jr. over vaccine panel overhaul

The Hill

time2 hours ago

  • The Hill

Biden's COVID czar hammers RFK Jr. over vaccine panel overhaul

Former White House COVID-19 response coordinator Ashish Jha, who served under President Biden, criticized the decision by Health and Human Services (HHS) Secretary Robert F. Kennedy Jr. to fire all 17 experts on the U.S. Centers for Disease Control and Prevention's (CDC) vaccine panel. Kennedy announced the decision in an op-ed for The Wall Street Journal Monday, saying, 'A clean sweep is needed to re-establish public confidence in vaccine science.' But in an interview with CNN's Wolf Blitzer, Jha pushed back against Kennedy's reasoning. 'Look what he said in his op-ed was a series of nonsense about a group of individuals, experts…who shape what vaccines, if any, are going to be available to the American people,' Jha said in the interview. 'So obviously this is very concerning,' he continued. 'We'll have to see who he appoints next. But this is a step in the wrong direction.' Jha said he is concerned about what the move foretells about the secretary's agenda on vaccines. Jha pointed to what he characterized as a lackluster response from the secretary to 'the worst measles outbreak of the last 25 years.' He also expressed concern about Kennedy raising questions about vaccines causing autism, which Jha dismissed and said was 'settled science.' 'Then you put this in the middle of all of that,' Jha said, referring to the vaccine panel sweep, 'and what you have is a pretty clear picture that what Secretary Kennedy is trying to do is make sure that vaccines are not readily available to Americans, not just for kids, for the elderly.' 'He could go pretty far with this move, and I really am worried about where we're headed,' Jha continued. He said he's particularly concerned about the effect Kennedy's move will have on kids and whether they will continue having access to certain vaccines in the future. 'Kids rely on vaccines. I'm worried about whether the next generation of kids are going to have access to polio vaccines and measles vaccines. That's where we're heading. That's what we have to push back against.' Kennedy said in his op-ed that he was removing every member of the panel to give the Trump administration an opportunity to appoint its own members. Kennedy has long accused ACIP members of having conflicts of interest, sparking concern among vaccine advocates that he would seek to install members who are far more skeptical of approving new vaccines. But Jha pushed back against criticism that the panel was all Biden-appointed experts, saying, 'When the Biden administration came in, almost all of the appointees had come from the first Trump administration.' 'That was fine because they were good people,' he said. 'They were experts. Right now, it's the same thing. The people he is firing are experts — like a nurse in Illinois who spent her entire career getting kids vaccinated, cancer doctors from Memorial Sloan Kettering — like these are really good people.' 'And generally, CDC has not worried about when were they appointed. The question is, are they good and are they conflict free.'

Trump administration vs. mRNA vaccines
Trump administration vs. mRNA vaccines

The Hill

time2 hours ago

  • The Hill

Trump administration vs. mRNA vaccines

The Big Story President Trump once heralded the speedy development of an mRNA vaccine, but his new administration is casting doubts and fostering speculation over their use. © AP The Department of Health and Human Services (HHS) in late May canceled $766 million awarded to Moderna through the Biomedical Advanced Research and Development Authority (BARDA) to develop a potential mRNA vaccine for bird flu. This came soon after HHS Secretary Robert F. Kennedy Jr. announced COVID-19 mRNA vaccines would no longer be recommended for children and pregnant women, though the Centers for Disease Control and Prevention (CDC) kept the shot on its schedule of childhood vaccinations. The vaccines marked a breakthrough in medical technology, drastically reducing the timeline for development of targeted vaccines and even showing promise in cancer research. Trump called mRNA the 'gold standard' when he rolled out the first COVID-19 vaccines. In remarks in December 2020, the same month the first COVID-19 vaccines were deployed, Trump praised Operation Warp Speed's ability to develop a SARS-CoV-2 vaccine at a 'breakneck speed,' adding, 'the gold standard vaccine has been done in less than nine months.' According to Joseph Varon, president and chief medical officer of the Independent Medical Alliance, the concerns for mRNA vaccine skeptics are the expedited timeline and the conditions in which the COVID-19 vaccine was approved. 'The biggest concern is that this rushed treatment still remains in use, even under an Emergency Use Authorization in some cases. It needs to be sent back through proper studies and vetting,' Varon told The Hill. In a move that could prevent future mRNA vaccines from receiving approval, Kennedy on Tuesday announced he was removing every member of the independent panel advising the CDC on vaccines. In a Wall Street Journal op-ed, he wrote, 'A clean sweep is needed to re-establish public confidence in vaccine science.' Welcome to The Hill's Health Care newsletter, we're Nathaniel Weixel, Joseph Choi and Alejandra O'Connell-Domenech — every week we follow the latest moves on how Washington impacts your health. Did someone forward you this newsletter? Subscribe here. Essential Reads How policy will be impacting the health care sector this week and beyond: Senators grill NIH director in budget hearing: 4 takeaways National Institutes of Health Director Jay Bhattacharya faced questions from senators during an Appropriations subcommittee hearing Tuesday, as the federal government agency has taken hits to its staffing levels and grant-making ability since under President Trump. Senators focused on the Trump administration's requested 2026 budget, which calls for cutting NIH's funding by $18 billion from 2025 levels. … States sue 23andMe over genetic data sales More than two dozen states, along with the District of Columbia, are suing biotechnology company 23andMe over plans to auction off personal genetic information without their customers' knowledge or consent. 'The Pitt' actor Noah Wyle to make push for health care workers at Capitol Noah Wyle is heading to the pit of political power, with a visit to Capitol Hill to push for funding for programs aimed at improving mental health services for health care workers. 'The Pitt' and former 'ER' star will touch down in Washington on Thursday to lead a panel discussion at the Cannon House Office Building focused on the 'daily mental health, financial, and bureaucratic challenges for … In Other News Branch out with a different read: Collins calls Kennedy's firing of vaccine experts 'excessive' Sen. Susan Collins (R-Maine) on Monday called Health and Human Services Secretary Robert F. Kennedy Jr.'s firing of all 17 experts on the U.S. Centers for Disease Control and Prevention's (CDC) vaccine panel 'excessive,' but she cautioned she needs to learn more about the decision. Kennedy announced the decision in an op-ed for The Wall Street Journal, catching many GOP lawmakers by surprise. 'I did not know that that had happened,' … Around the Nation Local and state headlines on health care: What We're Reading Health news we've flagged from other outlets: What Others are Reading Most read stories on The Hill right now: Judge declines to block Trump's Corporation for Public Broadcasting firings but allows board members to stay Correction: A previous version of this article gave incorrect names of the fired CPB board members. They are Laura Ross, Diane Kaplan and Thomas Rothman. … Read more Newsom asks judge for emergency intervention in Trump troop deployment in LA California Gov. Gavin Newsom (D) asked a federal judge to immediately intervene on Tuesday to limit President Trump's deployment of the National … Read more You're all caught up. See you tomorrow! Thank you for signing up! Subscribe to more newsletters here

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store